12:00 AM
 | 
Jan 28, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Bexsero regulatory update

Novartis said the European Commission approved Bexsero to vaccinate against meningococcal disease caused by Neisseria meningitides in individuals...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >